Notice Regarding Status of Own Share Repurchase

Nakanishi Inc. (the “Company”) hereby announces the status of the Company’s own Kanuma, Mar. 4, 2024
share repurchase resolved in the Board of Directors meeting held on February 20,
2024, in accordance with Article 156 of the Corporate Law and pursuant to Article
Contact
165, Item 3, of the Corporate Law as below.
Investors
Daisuke Suzuki
Corporate Vice President & Group CFO

Masatoshi Akiya
Head of Corporate Communication
Common stock of the Company
Nobue Ebihara
Corporate Communication Specialist

Saki Tabei
Corporate Communication Specialist

0 share ir@nsk-nakanishi.co.jp

Media
Yukino Kurosawa
Corporate Communication Specialist

JPY 0 Kazuki Takagi
Corporate Communication Specialist

pr@nsk-nakanishi.co.jp



From February 26, 2024 to February 29, 2024 (on a contract basis)
About Nakanishi inc.
Nakanishi raises as our mission the
creation of “brilliant progress” via
innovative “grinding technology”
through the lens of our corporate
(1) Class of shares to be repurchased Common shares
philosophy “Our Core” values.
(2) Total number of shares to be repurchased 1,100,000 shares (Maximum) We aim to contribute to the
(1.29% of total number of shares outstanding (excluding treasury shares)) development of medical care and
(3) Total amount of repurchase costs JPY 2,000,000,000 (Maximum) the realization of a better life for all
by creating new technology.
(4) Period of repurchase From February 26, 2024 to March 22, 2024
Based on “grinding technology”,
(5) Repurchase method Open market purchase through the Tokyo Stock Exchange
we have a differentiated product
based on a discretionary trading contract
lineup under world-class brands in
the dental, surgical, and industrial
business fields, and are sold in 145
countries around the world.

Nakanishi will continue to work
(1) Total number of shares repurchased 0 share together with all employees of the
(2) Total amount of repurchase costs JPY 0 group companies to create
innovative products that only we can
create and contribute to the lives and
health of people around the world.


The company’s shares are listed in
the Tokyo Stock Exchange.


Note: This document is a translation of the original Japanese document and is only for reference purposes. All readers Visit www.en.nakanishi-inc.jp for
are recommended to refer to the original version in Japanese of the release for complete information. more information about Nakanishi
Source: Nakanishi Inc. www.nakanishi-inc.jp/ir/irnews Inc. and our business.